# Time to Remission of Depressive Symptoms With Combined SSRI and Ramelteon

> **NCT00642694** · PHASE3 · TERMINATED · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 29 (actual)

## Conditions studied

- Major Depressive Disorder
- Insomnia

## Interventions

- **DRUG:** Escitalopram
- **DRUG:** Ramelteon
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00642694
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-05
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 29 (ACTUAL)
- **Why stopped:** Enrollment discontinued based on mutually agreed upon decision by PI and funding sponsor
- **Last updated:** 2019-07-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00642694

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00642694, "Time to Remission of Depressive Symptoms With Combined SSRI and Ramelteon". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00642694. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*